» Articles » PMID: 33778758

Upgrade Rate of Pure Flat Epithelial Atypia Diagnosed at Core Needle Biopsy: A Systematic Review and Meta-Analysis

Overview
Specialties Oncology
Radiology
Date 2021 Mar 29
PMID 33778758
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To perform a systematic review and meta-analysis to calculate the pooled upgrade rate of pure flat epithelial atypia (FEA) diagnosed at core needle biopsy (CNB).

Materials And Methods: A PubMed and Embase database search was performed in December 2019. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Study quality and publication bias were assessed. The upgrade rate of pure FEA to cancer, invasive carcinoma, and ductal carcinoma in situ (DCIS), as well as the co-occurrence rate of atypical ductal hyperplasia (ADH), with 95% CIs were calculated. A random effect model was used to integrate the proportions and their corresponding 95% CI. Study heterogeneity was calculated using τ and .

Results: A total of 2482 cases of pure FEA across 42 studies (mean age range, 46-59 years) met inclusion criteria to be analyzed. Significant study heterogeneity was identified (τ = 0.001, = 67%). The pooled upgrade rates reported for pure FEA were 5% (95% CI: 3%, 6%) for breast cancer, 1% (95% CI: 0%, 2%) for invasive carcinoma, and 2% (95% CI: 1%, 3%) for DCIS. When more than 90% of calcifications were removed at CNB, the pooled upgrade rate was 0% (95% CI: 0%, 2%). The pooled co-occurrence rate of ADH at surgical excision was 17% (95% CI: 12%, 21%). Study quality was medium to high with a risk of publication bias ( < .01).

Conclusion: Pure FEA diagnosed at CNB should be surgically excised due to the pooled upgrade rate of 5% for breast cancer. If more than 90% of the targeted calcifications are removed by CNB for pure FEA, close imaging follow-up is recommended. Biopsy/Needle Aspiration, Breast, Mammography© RSNA, 2021.

Citing Articles

Malignant upgrade in lesions of uncertain malignant potential in the breast (B3 lesions) - is open excision always necessary?.

Heindl F, Schiel J, Hack C, Amann N, Jud S, Preuss C Breast Cancer Res Treat. 2025; .

PMID: 39960605 DOI: 10.1007/s10549-025-07632-7.


Navigating the Uncertainty of B3 Breast Lesions: Diagnostic Challenges and Evolving Management Strategies.

DArchi S, Carnassale B, Sanchez A, Accetta C, Belli P, De Lauretis F J Pers Med. 2025; 15(1).

PMID: 39852228 PMC: 11766555. DOI: 10.3390/jpm15010036.


Assessing Malignant Risk in B3 Breast Lesions: Clinical Insights and Implications.

DArchi S, Carnassale B, Accetta C, Belli P, De Lauretis F, Di Guglielmo E J Clin Med. 2025; 14(1.

PMID: 39797153 PMC: 11721960. DOI: 10.3390/jcm14010070.


Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.

Park-Simon T, Muller V, Albert U, Banys Paluchowski M, Bauerfeind I, Blohmer J Breast Care (Basel). 2024; 19(3):165-182.

PMID: 38894952 PMC: 11182637. DOI: 10.1159/000538596.


Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.

Park-Simon T, Muller V, Jackisch C, Albert U, Banys-Paluchowski M, Bauerfeind I Breast Care (Basel). 2023; 18(4):289-305.

PMID: 37900552 PMC: 10601667. DOI: 10.1159/000531578.


References
1.
Acott A, Mancino A . Flat epithelial atypia on core needle biopsy, must we surgically excise?. Am J Surg. 2016; 212(6):1211-1213. DOI: 10.1016/j.amjsurg.2016.09.019. View

2.
Lamb L, Bahl M, Gadd M, Lehman C . Flat Epithelial Atypia: Upgrade Rates and Risk-Stratification Approach to Support Informed Decision Making. J Am Coll Surg. 2017; 225(6):696-701. DOI: 10.1016/j.jamcollsurg.2017.08.022. View

3.
Calhoun B, Sobel A, White R, Gromet M, Flippo T, Sarantou T . Management of flat epithelial atypia on breast core biopsy may be individualized based on correlation with imaging studies. Mod Pathol. 2014; 28(5):670-6. DOI: 10.1038/modpathol.2014.159. View

4.
Mooney K, Bassett L, Apple S . Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol. 2016; 29(12):1471-1484. DOI: 10.1038/modpathol.2016.127. View

5.
Ahn H, Jang M, Kim S, Yun B, Kim S, Kang E . Diagnosis of Columnar Cell Lesions and Atypical Ductal Hyperplasia by Ultrasound-Guided Core Biopsy: Findings Associated with Underestimation of Breast Carcinoma. Ultrasound Med Biol. 2016; 42(7):1457-63. DOI: 10.1016/j.ultrasmedbio.2016.02.009. View